NPI registry status
Active
2026 NPPES data Pediatric Hematology & Oncology Physician NPI 1487920807 M.D.
Verify on CMS → Laura Agresta, M.D.
Pediatric Hematology & Oncology Physician in Ann Arbor, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,666 in Pediatric Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
11
Medicare Part D claims · Pediatric Hematology & Oncology Physician avg: 88
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Laura Agresta, M.D. filed 11 Medicare Part D claims in 2024 as a Pediatric Hematology & Oncology Physician in Ann Arbor, Michigan, prescribing 0% generic.
- 11
- Part D claims, 2024
- 0%
- generic prescribing
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Laura Agresta, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1487920807), first enumerated 03/29/2012.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 11 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Michigan statewide board action statistics are published annually — these figures describe aggregate state activity, not Laura Agresta, M.D.'s individual license status. Verify directly with the state medical board.
Source: MI-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1487920807 · Pediatric Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1487920807
- ENUM-MID 2012
- TAX-NARROW 2,666
- RX-TRACE 11
- BOOK-THIN 69 in Michigan
- PHOTO-ENUM April Depombo · 2012
Laura Agresta, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
11 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Laura Agresta, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Laura Agresta, M.D.?
Quality data not reportedPrimary specialty
Pediatric Hematology & Oncology Physician
Medicare Part D claims
11 87% vs specialty avg
Specialty distribution in Michigan
How Pediatric Hematology & Oncology Physician compares to other specialties among Michigan providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1487920807 |
|---|---|
| Specialty | Pediatric Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 03/29/2012 |
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Laura Agresta, M.D.. To verify Laura Agresta, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Laura Agresta, M.D. - brand share 100.0%
Pediatric Hematology & Oncology Physician average
100% brand-name claims vs 0% generic, on 11 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
11
Total Claims
$6K
Total Drug Cost
N/A
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 11
- Total Day Supply
- 330
- Brand vs Generic
- 100% brand / 0% generic
- Brand Drug Cost
- $6K
- Generic Drug Cost
- $0
Patient Demographics
- Average Patient Age
- 23.0 years
- Avg HCC Risk Score
- 0.85
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Pediatric Hematology & Oncology Physician in MI →
All providers in Michigan →
Compare specialties →
Pediatric Hematology & Oncology Physician Overview
How Laura Agresta, M.D. fits within the Pediatric Hematology & Oncology Physician landscape nationally.
2,666
Pediatric Hematology & Oncology Physician Providers in US
52
States with Pediatric Hematology & Oncology Physician
88
Avg Claims per Provider
Laura Agresta, M.D.'s 11 claims are below the specialty average of 88.
Nationwide Pediatric Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Agresta, both outside Michigan so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pediatric Hematology & Oncology Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Agresta.
One of 69 Pediatric Hematology & Oncology Physician providers enrolled in Michigan, 5 are shown here.
Dr. Aly Abdel-Mageed
MD
Grand Rapids, MI
Dr. Jennifer Agrusa
M.D.
Ann Arbor, MI
Dr. Raana Ali
DO
Detroit, MI
Dr. Adoor Amanullah
MD
Royal Oak, MI
Dr. Richard Axtell
MD
Grand Rapids, MI
Compare Pediatric Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Laura Agresta, M.D.'s specialty? ▼
Laura Agresta, M.D. specializes in Pediatric Hematology & Oncology Physician and practices in Ann Arbor, Michigan. Credentials: M.D..
How much does Laura Agresta, M.D. prescribe under Medicare Part D? ▼
In 2024, Laura Agresta, M.D. wrote 11 Medicare Part D claims totaling $6K in drug costs for N/A beneficiaries.
Where is Laura Agresta, M.D. located? ▼
Laura Agresta, M.D. is located at 343 N MAPLE RD, Ann Arbor, MI, 48103. Phone: (734) 475-4500.
What is Laura Agresta, M.D.'s NPI number? ▼
Laura Agresta, M.D.'s National Provider Identifier (NPI) is 1487920807, issued on 03/29/2012.
Does Laura Agresta, M.D. prescribe more brand-name or generic drugs? ▼
Laura Agresta, M.D.'s prescribing is 100% brand-name and 0% generic drugs by claim count, with $6K in brand drug costs.
How many Pediatric Hematology & Oncology Physician providers are there in the US? ▼
There are 2,666 Pediatric Hematology & Oncology Physician providers across 52 states in the US. The average Pediatric Hematology & Oncology Physician provider writes 88 Medicare Part D claims per year.
What drugs does Laura Agresta, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Laura Agresta, M.D.'s most frequently prescribed drugs include Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Laura Agresta, M.D. accept Medicare? ▼
Laura Agresta, M.D. appears in CMS Medicare data with 11 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Laura Agresta, M.D.'s credentials? ▼
Laura Agresta, M.D.'s NPI is 1487920807 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.